Does North Carolina Medicaid cover GLP-1s for weight loss?
Does North Carolina Medicaid cover GLP-1s for weight loss?
North Carolina Medicaid covers GLP-1 receptor agonists for obesity, subject to prior authorization. Coverage for type 2 diabetes, for Wegovy's cardiovascular indication and for Zepbound in moderate to severe sleep apnea is required of every state program regardless. So the practical question at a denial is rarely "does my state cover it" but "which indication am I being prescribed this under". The published threshold is: 18 and over: 30 or more, or 27 or more with a weight-related comorbidity — hypertension, type 2 diabetes, obstructive sleep apnea, cardiovascular disease or dyslipidemia. 12–17: the 95th percentile for age and sex, or 30, or the 85th percentile with at least one severe weight-related comorbidity. Separately, 45 and over with established cardiovascular disease qualifies at 27. Baseline weight and BMI must be measured within 45 days of the request. For renewal: 5% body weight loss for adults, 4% BMI reduction for adolescents, and it has to hold.
What North Carolina changed, and when
- 2025-12-12 — Coverage reinstated, reverting to the criteria in force on 30 September 2025 the document that says so
- 2025-10-01 — GLP-1s for obesity dropped during the state budget stalemate the document that says so
What the prior authorization asks for
- BMI threshold
- 18 and over: 30 or more, or 27 or more with a weight-related comorbidity — hypertension, type 2 diabetes, obstructive sleep apnea, cardiovascular disease or dyslipidemia. 12–17: the 95th percentile for age and sex, or 30, or the 85th percentile with at least one severe weight-related comorbidity. Separately, 45 and over with established cardiovascular disease qualifies at 27. Baseline weight and BMI must be measured within 45 days of the request.
- Tried first
- The preferred drug on the state's PDL has to be tried first, and the trial means an adequate titration period of 3 to 6 months of it, unless a contraindication is documented — the criteria document sets that rule without naming which agent is preferred. Lifestyle change has to be under way, no second GLP-1 alongside, and no FDA-labeled contraindication.
- To keep it
- 5% body weight loss for adults, 4% BMI reduction for adolescents, and it has to hold
- Age
- Wegovy and Saxenda 12+, Zepbound 18+
- Approval runs for
- 6 months, then 12-month renewals
The copy North Carolina publishes at this link is stamped DRAFT, and its change log gives these criteria an effective date of 1 August 2024 and an end date of 30 September 2025 — the day coverage was cut in the budget stalemate. Coverage was reinstated on 12 December 2025 under the criteria in force on 30 September, which are these.
Both tools fill from these criteria rather than from a template — a prior authorization for North Carolina, or a letter appealing a denial. If the plan is not Medicaid, the 9 insurer and program pages cover a different set of rules.
Whatever North Carolina decides about obesity, federal law still makes it cover a GLP-1 prescribed for type 2 diabetes, Wegovy for cardiovascular risk reduction and Zepbound for obstructive sleep apnea — the exclusion is written against the use, not the drug. Which approval a weight-loss exclusion cannot reach, and what each label says.
If you end up paying cash
The cheapest verified GLP-1 routes — what you pay per month once titrated, not an introductory rate:
- Strut Health$129/moverified 2026-09-22compounded, not FDA approvedFDA warning letter
- Noom Med$249/moverified 2026-09-22compounded, not FDA approved
- Found$289/moverified 2026-09-22compounded, not FDA approved
Cheaper still, and a different class: Qsymia (phentermine/topiramate) at $75/mo — about 9.8% mean weight loss in its trial, against roughly 15 to 21% for the GLP-1s above. It is a real option and it is not a substitute.
The manufacturer programs cut the first fills further, and each one's catch is printed with it. Write the appeal first if you were refused — it costs nothing and the criteria above are what it has to answer.
Other states with criteria of their own
Source: NC Medicaid Outpatient Pharmacy Prior Approval Criteria — GLP-1s for Weight Management , effective 2024-08-01. Read on 2026-09-05. Fee-for-service rules; a managed-care plan in North Carolina can publish its own formulary and step edits. This is a record of what the payer publishes, not medical or legal advice.